Moderna, Inc. (NASDAQ:MRNA) Q1 2024 Earnings Call Transcript May 2, 2024
Moderna, Inc. beats earnings expectations. Reported EPS is $-3.07, expectations were $-3.56. MRNA isn’t one of the 30 most popular stocks among hedge funds at the end of the third quarter (see the details here).
Operator: Good day, and thank you for standing by. Welcome to the Moderna’s First Quarter 2024 Conference Call. At this time, all participants are in a listen-only mode. After the speaker’s presentation,...
